WO2014060431A1 - Pyrrolotriazinone derivatives as pi3k inhibitors - Google Patents
Pyrrolotriazinone derivatives as pi3k inhibitors Download PDFInfo
- Publication number
- WO2014060431A1 WO2014060431A1 PCT/EP2013/071550 EP2013071550W WO2014060431A1 WO 2014060431 A1 WO2014060431 A1 WO 2014060431A1 EP 2013071550 W EP2013071550 W EP 2013071550W WO 2014060431 A1 WO2014060431 A1 WO 2014060431A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- phenyl
- methyl
- branched
- linear
- Prior art date
Links
- 0 *c1c(*)[n]c(C(O)=O)c1* Chemical compound *c1c(*)[n]c(C(O)=O)c1* 0.000 description 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12382398.1 | 2012-10-16 | ||
EP12382398 | 2012-10-16 | ||
US201261718787P | 2012-10-26 | 2012-10-26 | |
US61/718,787 | 2012-10-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014060431A1 true WO2014060431A1 (en) | 2014-04-24 |
Family
ID=47049113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2013/071550 WO2014060431A1 (en) | 2012-10-16 | 2013-10-15 | Pyrrolotriazinone derivatives as pi3k inhibitors |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR093035A1 (es) |
TW (1) | TW201422627A (es) |
UY (1) | UY35087A (es) |
WO (1) | WO2014060431A1 (es) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US9701706B2 (en) | 2015-08-06 | 2017-07-11 | Chimerix, Inc. | Pyrrolopyrimidine nucleosides and analogs thereof |
US9775841B2 (en) | 2011-05-04 | 2017-10-03 | Rhizen Pharmaceuticals Sa | Compounds as modulators of protein kinases |
WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US9944639B2 (en) | 2014-07-04 | 2018-04-17 | Lupin Limited | Quinolizinone derivatives as PI3K inhibitors |
WO2018094137A1 (en) | 2016-11-18 | 2018-05-24 | Cystic Fibrosis Foundation Therapeutics Inc. | Pyrrolopyrimidines as cftr potentiators |
CN112645971A (zh) * | 2021-01-20 | 2021-04-13 | 中国科学院兰州化学物理研究所 | 一种烷基卤代物直接制备烷基硼酸酯类化合物的方法 |
US11111264B2 (en) | 2017-09-21 | 2021-09-07 | Chimerix, Inc. | Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereof |
US11981700B2 (en) | 2016-04-15 | 2024-05-14 | Chimerix, Inc. | Pyrrolopyrimidine nucleosides and analogs thereof |
Citations (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2041763A (en) | 1979-02-05 | 1980-09-17 | Chiesi P | An inhalor for pulverulent medicinal substances |
EP0069715A1 (en) | 1981-07-08 | 1983-01-12 | Aktiebolaget Draco | Powder inhalator |
EP0166294A2 (en) | 1984-06-18 | 1986-01-02 | Miles Inc. | Medicament inhalation device |
GB2165159A (en) | 1984-10-04 | 1986-04-09 | Orion Yhtymae Oy | Dosing device |
WO1991002558A1 (de) | 1989-08-17 | 1991-03-07 | Boehringer Ingelheim Kg | Inhalator |
EP0424790A2 (en) | 1989-10-27 | 1991-05-02 | Miat S.P.A. | Multi-dose inhaler for medicaments in powder form |
GB2242134A (en) | 1990-03-02 | 1991-09-25 | Glaxo Group Ltd | Inhalation device |
WO1991014468A1 (en) | 1990-03-21 | 1991-10-03 | Dmw (Technology) Limited | Atomising devices and methods |
WO1992000771A1 (en) | 1990-07-13 | 1992-01-23 | Innovata Biomed Limited | Inhaler |
WO1992003175A1 (en) | 1990-08-11 | 1992-03-05 | Fisons Plc | Inhalation device |
WO1992004068A1 (de) | 1990-08-30 | 1992-03-19 | Boehringer Ingelheim Kg | Treibgasfreies inhalationsgerät mit fremdluftstrom |
WO1992004928A2 (en) | 1990-09-26 | 1992-04-02 | Pharbita B.V. | Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber |
WO1992009322A1 (en) | 1990-11-29 | 1992-06-11 | Boehringer Ingelheim Kg | Inhalation device |
EP0505321A2 (de) | 1991-03-21 | 1992-09-23 | Ciba-Geigy Ag | Inhalator |
US5201308A (en) | 1990-02-14 | 1993-04-13 | Newhouse Michael T | Powder inhaler |
DE4239402A1 (de) | 1992-11-24 | 1994-05-26 | Bayer Ag | Pulverinhalator |
EP0674533A1 (en) | 1992-12-18 | 1995-10-04 | Schering Corporation | Inhaler for powdered medications |
WO1996032150A1 (en) | 1995-04-14 | 1996-10-17 | Glaxo Wellcome Inc. | Metered dose inhaler for salmeterol |
WO1997000703A1 (en) | 1995-06-21 | 1997-01-09 | Asta Medica Aktiengesellschaft | Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments |
WO1997012687A1 (en) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim International Gmbh | Device of miniaturised construction for producing high pressure in a fluid to be atomised |
WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
US6106864A (en) | 1995-09-15 | 2000-08-22 | Pfizer Inc. | Pharmaceutical formulations containing darifenacin |
WO2003000325A1 (en) | 2001-06-22 | 2003-01-03 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder |
WO2003097613A1 (en) | 2002-05-16 | 2003-11-27 | Almirall Prodesfarma Sa | Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
WO2004058729A1 (en) | 2002-12-26 | 2004-07-15 | Almirall Prodesfarma Sa | New pyridazin-3(2h)-one derivatives |
WO2005049581A1 (en) | 2003-11-10 | 2005-06-02 | Almirall Prodesfarma, S.A. | Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors |
WO2005123692A1 (en) | 2004-06-18 | 2005-12-29 | Laboratorios Almirall, S.A. | Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
WO2005123693A1 (en) | 2004-06-21 | 2005-12-29 | Laboratorios Almirall, S.A. | Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
WO2006008027A1 (en) | 2004-07-16 | 2006-01-26 | Laboratorios Almirall, S.A. | Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler |
WO2006122788A1 (en) | 2005-05-20 | 2006-11-23 | Laboratorios Almirall, S.A. | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
WO2007124898A1 (en) | 2006-04-27 | 2007-11-08 | Laboratorios, Almirall S.A. | DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
WO2008046598A1 (en) | 2006-10-20 | 2008-04-24 | Laboratorios Almirall, S.A. | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
WO2008077639A1 (en) | 2006-12-22 | 2008-07-03 | Laboratorios Almirall, S.A. | Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors |
WO2008095720A1 (en) | 2007-02-09 | 2008-08-14 | Almirall, S.A. | Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
US7417055B2 (en) | 2003-04-25 | 2008-08-26 | Gilead Sciences, Inc. | Kinase inhibitory phosphonate analogs |
WO2009021696A1 (en) | 2007-08-10 | 2009-02-19 | Almirall, S.A. | Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
WO2009068177A1 (en) | 2007-11-28 | 2009-06-04 | Almirall, S.A. | DERIVATIVES OF 4-(2-AMINO-1 -HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
WO2009153043A1 (en) | 2008-06-20 | 2009-12-23 | Almirall, S.A. | Combinations comprising methotrexate and dhodh inhibitors |
WO2010069504A1 (en) | 2008-12-15 | 2010-06-24 | Almirall, S.A. | (3-oxo)pyridin-4-ylurea derivatives as pde4 inhibitors |
WO2010072354A1 (en) | 2008-12-22 | 2010-07-01 | Almirall, S.A. | MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO }-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR |
WO2010083975A1 (en) | 2009-01-21 | 2010-07-29 | Almirall, S.A. | Combinations comprising methotrexate and dhodh inhibitors |
WO2010111432A1 (en) * | 2009-03-24 | 2010-09-30 | Calistoga Pharmaceuticals Inc. | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
WO2011058109A1 (en) * | 2009-11-12 | 2011-05-19 | Ucb Pharma S.A. | Fused bicyclic pyrrole and imidazole derivatives as kinase inhibitors |
-
2013
- 2013-10-15 WO PCT/EP2013/071550 patent/WO2014060431A1/en active Application Filing
- 2013-10-16 AR ARP130103756A patent/AR093035A1/es unknown
- 2013-10-16 TW TW102137258A patent/TW201422627A/zh unknown
- 2013-10-16 UY UY0001035087A patent/UY35087A/es not_active Application Discontinuation
Patent Citations (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2041763A (en) | 1979-02-05 | 1980-09-17 | Chiesi P | An inhalor for pulverulent medicinal substances |
EP0069715A1 (en) | 1981-07-08 | 1983-01-12 | Aktiebolaget Draco | Powder inhalator |
EP0166294A2 (en) | 1984-06-18 | 1986-01-02 | Miles Inc. | Medicament inhalation device |
GB2165159A (en) | 1984-10-04 | 1986-04-09 | Orion Yhtymae Oy | Dosing device |
WO1991002558A1 (de) | 1989-08-17 | 1991-03-07 | Boehringer Ingelheim Kg | Inhalator |
EP0424790A2 (en) | 1989-10-27 | 1991-05-02 | Miat S.P.A. | Multi-dose inhaler for medicaments in powder form |
US5201308A (en) | 1990-02-14 | 1993-04-13 | Newhouse Michael T | Powder inhaler |
GB2242134A (en) | 1990-03-02 | 1991-09-25 | Glaxo Group Ltd | Inhalation device |
WO1991014468A1 (en) | 1990-03-21 | 1991-10-03 | Dmw (Technology) Limited | Atomising devices and methods |
WO1992000771A1 (en) | 1990-07-13 | 1992-01-23 | Innovata Biomed Limited | Inhaler |
WO1992003175A1 (en) | 1990-08-11 | 1992-03-05 | Fisons Plc | Inhalation device |
WO1992004068A1 (de) | 1990-08-30 | 1992-03-19 | Boehringer Ingelheim Kg | Treibgasfreies inhalationsgerät mit fremdluftstrom |
WO1992004928A2 (en) | 1990-09-26 | 1992-04-02 | Pharbita B.V. | Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber |
WO1992009322A1 (en) | 1990-11-29 | 1992-06-11 | Boehringer Ingelheim Kg | Inhalation device |
EP0505321A2 (de) | 1991-03-21 | 1992-09-23 | Ciba-Geigy Ag | Inhalator |
DE4239402A1 (de) | 1992-11-24 | 1994-05-26 | Bayer Ag | Pulverinhalator |
EP0674533A1 (en) | 1992-12-18 | 1995-10-04 | Schering Corporation | Inhaler for powdered medications |
WO1996032150A1 (en) | 1995-04-14 | 1996-10-17 | Glaxo Wellcome Inc. | Metered dose inhaler for salmeterol |
WO1997000703A1 (en) | 1995-06-21 | 1997-01-09 | Asta Medica Aktiengesellschaft | Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments |
US6106864A (en) | 1995-09-15 | 2000-08-22 | Pfizer Inc. | Pharmaceutical formulations containing darifenacin |
WO1997012687A1 (en) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim International Gmbh | Device of miniaturised construction for producing high pressure in a fluid to be atomised |
WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
WO2003000325A1 (en) | 2001-06-22 | 2003-01-03 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder |
WO2003097613A1 (en) | 2002-05-16 | 2003-11-27 | Almirall Prodesfarma Sa | Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
WO2004058729A1 (en) | 2002-12-26 | 2004-07-15 | Almirall Prodesfarma Sa | New pyridazin-3(2h)-one derivatives |
US7417055B2 (en) | 2003-04-25 | 2008-08-26 | Gilead Sciences, Inc. | Kinase inhibitory phosphonate analogs |
WO2005049581A1 (en) | 2003-11-10 | 2005-06-02 | Almirall Prodesfarma, S.A. | Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors |
WO2005123692A1 (en) | 2004-06-18 | 2005-12-29 | Laboratorios Almirall, S.A. | Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
WO2005123693A1 (en) | 2004-06-21 | 2005-12-29 | Laboratorios Almirall, S.A. | Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
WO2006008027A1 (en) | 2004-07-16 | 2006-01-26 | Laboratorios Almirall, S.A. | Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler |
WO2006122788A1 (en) | 2005-05-20 | 2006-11-23 | Laboratorios Almirall, S.A. | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
WO2007124898A1 (en) | 2006-04-27 | 2007-11-08 | Laboratorios, Almirall S.A. | DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
WO2008046598A1 (en) | 2006-10-20 | 2008-04-24 | Laboratorios Almirall, S.A. | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
WO2008077639A1 (en) | 2006-12-22 | 2008-07-03 | Laboratorios Almirall, S.A. | Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors |
WO2008095720A1 (en) | 2007-02-09 | 2008-08-14 | Almirall, S.A. | Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
WO2009021696A1 (en) | 2007-08-10 | 2009-02-19 | Almirall, S.A. | Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
WO2009068177A1 (en) | 2007-11-28 | 2009-06-04 | Almirall, S.A. | DERIVATIVES OF 4-(2-AMINO-1 -HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
WO2009153043A1 (en) | 2008-06-20 | 2009-12-23 | Almirall, S.A. | Combinations comprising methotrexate and dhodh inhibitors |
WO2010069504A1 (en) | 2008-12-15 | 2010-06-24 | Almirall, S.A. | (3-oxo)pyridin-4-ylurea derivatives as pde4 inhibitors |
WO2010072354A1 (en) | 2008-12-22 | 2010-07-01 | Almirall, S.A. | MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO }-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR |
WO2010083975A1 (en) | 2009-01-21 | 2010-07-29 | Almirall, S.A. | Combinations comprising methotrexate and dhodh inhibitors |
WO2010111432A1 (en) * | 2009-03-24 | 2010-09-30 | Calistoga Pharmaceuticals Inc. | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
WO2011058109A1 (en) * | 2009-11-12 | 2011-05-19 | Ucb Pharma S.A. | Fused bicyclic pyrrole and imidazole derivatives as kinase inhibitors |
Non-Patent Citations (50)
Title |
---|
"Bioreversible Carriers in Drug Design", 1987, PERGAMON PRESS |
"Remington: The Science and Practice of Pharmacy", 2001, LIPPINCOTT WILLIAMS & WILKINS |
AI-ALWAN M, JI, 2007 |
ALI K, JOURNAL OF IMMUNOLOGY, vol. 180, 2008, pages 2538 - 2544 |
ALI K, NATURE, vol. 431, 2004, pages 1007 - 1011 |
BILANCIO A, BLOOD, 2006, pages 107 |
CONDLIFFE AM, BLOOD, vol. 106, 2005 |
DIL N, MOL IMMUNOL, vol. 46, 2009 |
DOUKAS J, JPET, vol. 328, 2009, pages 758 |
DURAND CA, JI, 2009 |
ERNEST L. ELIEL: "Stereochemistry of Organic Compounds", 1994, WILEY |
EUR RESPIR J, vol. 22, no. 45, 2003 |
FINNIN; MORGAN, J PHARM SCI, vol. 88, no. 10, October 1999 (1999-10-01), pages 955 - 958 |
GRAY ET AL., ANAL BIOCHEM, vol. 313, 2003, pages 234 - 45 |
H. BUNDGAARD: "Design of Prodrugs", 1985, ELSEVIER |
H. LIEBERMAN; L. LACHMAN: "Pharmaceutical Dosage Forms: Tablets", vol. 1, 1980, MARCEL DEKKER |
HAYLOCK-JACOBS S, J. AUTOIMMUN, 2010 |
HERMAN SEM, BLOOD, 3 June 2010 (2010-06-03) |
HERMANN SE, BLOOD, vol. 116, 2010, pages 2078 - 88 |
JARMIN SJ, JCI, 2008 |
JI H, BLOOD, 2007 |
KOK K, TRENDS BIOCHEM SCIENCE, vol. 34, 2009, pages 115 - 127 |
LANNUTTI BJ, BLOOD, October 2010 (2010-10-01) |
LEE ET AL., FASEB J, vol. 20, 2006, pages 455 |
LEE KS ET AL., J ALLERGY CLIN IMMUNOL, vol. 118, 2006, pages 403 |
MARTIN AL, JI, vol. 180, 2008 |
MARWICK JA, JACI, vol. 125, 2010, pages 1146 - 53 |
MARWICK JA, JRCCM, vol. 179, 2009, pages 542 - 548 |
MATTHEW T, IMMUNOLOGY, vol. 126, 2008 |
NASHED, EUR J IMMUNOL, vol. 37, 2007, pages 416 |
OKKENHAUG K, SCIENCE, 2002 |
PAR SJ, ERJ, 2010 |
PINHO JF, BR. J. PHARMACOL, vol. 161, 2010 |
PINHO V, JI, vol. 179, 2007 |
PURI KD, BLOOD, vol. 103, 2004 |
PURI KD, BLOOD, vol. 103, 2004, pages 3448 |
RANDIS TM, EUR J IMMUNOL, vol. 38, 2008 |
SADHU C, BIOCHEM BIOPHYS RES COMM, vol. 308, 2003 |
SADHU C, JI, 2003, pages 170 |
SOOND DR, BLOOD, 2010 |
SOOND DR, BLOOD, January 2010 (2010-01-01) |
T. HIGUCHI; W. STELLA: "Novel Delivery Systems", vol. 14, ACS SYMPOSIUM SERIES |
T. W. GREENE; G. M. WUTS: "Protecting Groups in Organic Synthesis", 1999, WILEY |
THOMAS MS, J LEUKOC BIOL, vol. 84, 2008 |
TO Y, AJRCCM, 2010 |
TO Y, AJRCCM, vol. 182, 2010, pages 897 - 904 |
VANHAESEBROECK B, NAT REV MOL CELL BIOL, vol. 5, 2010, pages 11381 - 6 |
VERMA ET AL., PHARMACEUTICAL TECHNOLOGY ON-LINE, vol. 25, no. 2, 2001, pages 1 - 14 |
WILLIAM 0, CHEMISTRY & BIOLOGY, vol. 17, 2010 |
YUM HK, JI, vol. 167, 2001 |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10220035B2 (en) | 2011-05-04 | 2019-03-05 | Rhizen Pharmaceuticals Sa | Compounds as modulators of protein kinases |
US11020399B2 (en) | 2011-05-04 | 2021-06-01 | Rhizen Pharmaceuticals Sa | Intermediates useful in the synthesis of compounds as modulators of protein kinases |
US9775841B2 (en) | 2011-05-04 | 2017-10-03 | Rhizen Pharmaceuticals Sa | Compounds as modulators of protein kinases |
US10322130B2 (en) | 2011-05-04 | 2019-06-18 | Rhizen Pharmaceuticals Sa | Substituted chromenones as modulators of protein kinases |
US9944639B2 (en) | 2014-07-04 | 2018-04-17 | Lupin Limited | Quinolizinone derivatives as PI3K inhibitors |
WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US10941175B2 (en) | 2015-08-06 | 2021-03-09 | Chimerix, Inc. | Pyrrolopyrimidine nucleosides and analogs thereof |
US10407457B2 (en) | 2015-08-06 | 2019-09-10 | Chimerix, Inc. | Pyrrolopyrimidine nucleosides and analogs thereof |
US9708359B2 (en) | 2015-08-06 | 2017-07-18 | Chimerix, Inc. | Pyrrolopyrimidine nucleosides and analogs thereof |
US9701706B2 (en) | 2015-08-06 | 2017-07-11 | Chimerix, Inc. | Pyrrolopyrimidine nucleosides and analogs thereof |
US11981700B2 (en) | 2016-04-15 | 2024-05-14 | Chimerix, Inc. | Pyrrolopyrimidine nucleosides and analogs thereof |
WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
WO2018094137A1 (en) | 2016-11-18 | 2018-05-24 | Cystic Fibrosis Foundation Therapeutics Inc. | Pyrrolopyrimidines as cftr potentiators |
JP2020510668A (ja) * | 2016-11-18 | 2020-04-09 | システィック ファイブロシス ファンデーション セラピューティクス インコーポレイテッドCystic Fibrosis Foundation Therapeutics Inc. | Cftr増強物質としてのピロロピリミジン |
EP3541390A4 (en) * | 2016-11-18 | 2020-06-24 | Cystic Fibrosis Foundation | PYRROLOPYRIMIDINE AS CFTR POTENTIATORS |
RU2757457C2 (ru) * | 2016-11-18 | 2021-10-18 | Систик Файбросис Фаундейшн | Пирролопиримидины в качестве потенциаторов мвтр |
US11111264B2 (en) | 2017-09-21 | 2021-09-07 | Chimerix, Inc. | Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereof |
CN112645971A (zh) * | 2021-01-20 | 2021-04-13 | 中国科学院兰州化学物理研究所 | 一种烷基卤代物直接制备烷基硼酸酯类化合物的方法 |
CN112645971B (zh) * | 2021-01-20 | 2021-12-24 | 中国科学院兰州化学物理研究所 | 一种烷基卤代物直接制备烷基硼酸酯类化合物的方法 |
Also Published As
Publication number | Publication date |
---|---|
UY35087A (es) | 2014-05-30 |
TW201422627A (zh) | 2014-06-16 |
AR093035A1 (es) | 2015-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2012247491B2 (en) | Pyrrolotriazinone derivatives as PI3k inhibitors | |
US9388189B2 (en) | Pyrrolotriazinone derivatives as PI3K inhibitors | |
JP6776399B2 (ja) | PI3Kδ関連障害治療のためのピラゾロピリミジン誘導体の使用 | |
WO2012146667A1 (en) | Imidazopyridine derivatives as pi3k inhibitors | |
WO2014060431A1 (en) | Pyrrolotriazinone derivatives as pi3k inhibitors | |
WO2014124757A1 (en) | Pyrrolotriazine derivatives as pi3k inhibitors | |
CA2815029A1 (en) | Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as jak inhibitors | |
WO2015091531A1 (en) | Imidazolopyrimidin-2-yl derivatives as jak inhibitors | |
WO2015091532A1 (en) | Pyrrolopyrimidine derivatives as pi3k inhibitors | |
WO2016202800A1 (en) | Pyrrolotriazinone derivatives as pi3k inhibitors | |
NZ614082B2 (en) | Pyrrolotriazinone derivatives as pi3k inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13783004 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13783004 Country of ref document: EP Kind code of ref document: A1 |